[Comparison of effectiveness of treatment for cervical carcinoma using different brachytherapy equipment].
The immediate and end results of combined radiotherapy for cervical carcinoma stages I-III conducted at the N.N. Blokhin Center's Clinic (1982-1996) were compared. Intracavitary irradiation was carried out using the following radiation sources: 60Co-AGAT-V (208); 137Cs-Selectron (96) and 252Cf-ANET-V and ANET-VA (115). Remote-control irradiation procedure was identical in all groups. Five-year survival for stage I was 85.1% +/- 6.2; 85.7% +/- 13.1 and 87.8% +/- 1.2; stage II--67.5% +/- 4.0; 61% +/- 8.5 and 76.6 +/- 3.2; stage III--43.6% +/- 6.8; 57.7% +/- 9.6 and 70.9% +/- 5.4, respectively. Ten-year survival for stage I was 56.9% +/- 15.1; 85.4% +/- 13.1 and 80.1% +/- 1.5; stage II--65% +/- 5.2; 46.5% +/- 8.7 and 70.7% +/- 3.5; stage III--42% +/- 8.8; 51.3 +/- 9.9 and 64.6% +/- 6.2, respectively.
Mar'ina
L A
LA
N. N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.
Chekhonadskiĭ
V N
VN
Kravets
O A
OA
Rusanov
A O
AO
Kiseleva
V N
VN
Riadtseva
A M
AM
Sorokina
I I
II
Igleva
G M
GM
Shatrova
E P
EP
Kiseleva
M V
MV
D000328:Adult; D000368:Aged; D001918:Brachytherapy / Q000295:instrumentation*; D002142:Californium / Q000627:therapeutic use; D002588:Cesium Radioisotopes / Q000627:therapeutic use; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D016019:Survival Analysis; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000532:radiotherapy*
D002588:Cesium Radioisotopes; D003037:Cobalt Radioisotopes; D002142:Californium